Purple Biotech (PPBT) announced the appointment of Shai Lankry as its CFO. Prior to joining Purple Biotech, Mr. Lankry supported several companies as a strategic fractional CFO through his firm, LS Consulting Services.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PPBT:
- Purple Biotech Unveils Strategic Advancements in Oncology Therapies
- Purple Biotech Unveils Promising Phase 2 Results for CM24 in Pancreatic Cancer
- Purple Biotech announces significant efficacy results from Phase 2 CM24 study
- Purple Biotech Announces Promising NT219 Data for Cancer Treatment
- Purple Biotech reports NT219 data at AACR meeting